Xiaofei Zhu

9PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 11, 2026
Multifunctional Nanovaccine-Radiotherapy Synergy Drives Anti-Tumor Immunity via Multi-Cascade Cell Death for Pancreatic Cancer Therapy.

|May 09, 2026
Stage III Lymph Node-Positive Non-Small-Cell Lung Cancer Patients With or Without Lymph Node Irradiation by Stereotactic Body Radiation Therapy: Propensity Score-Matched Analysis.

|Jun 30, 2025
ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancer.

Xiaofei Zhu, Wenyu Liu, Lingong Jiang

|Jun 12, 2025
Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART).

Lingong Jiang, Yangsen Cao, Xiaolan Yin

|Apr 30, 2024
Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy.

Fang Fang, Zhen Jia, Hongliang Xie

|Jan 06, 2021
Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study.

Xiaofei Zhu, Yangsen Cao, Tingshi Su

Pageof 2

Frequent Collaborators

2 joint publications

Zhen Jia

1 joint publications

Chengyi Huang

1 joint publications

Xiang Liu

1 joint publications

Zhenyuan Miao